| 000 | 01892 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250513175032.0 | ||
| 264 | 0 | _c19990422 | |
| 008 | 199904s 0 0 eng d | ||
| 022 | _a0098-7484 | ||
| 024 | 7 |
_a10.1001/jama.281.14.1282 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStrawford, A | |
| 245 | 0 | 0 |
_aResistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial. _h[electronic resource] |
| 260 |
_bJAMA _cApr 1999 |
||
| 300 |
_a1282-90 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnabolic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBlood Chemical Analysis |
| 650 | 0 | 4 |
_aBody Composition _xdrug effects |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aEnergy Intake |
| 650 | 0 | 4 | _aEnergy Metabolism |
| 650 | 0 | 4 |
_aEunuchism _xcomplications |
| 650 | 0 | 4 | _aExercise |
| 650 | 0 | 4 |
_aHIV Infections _xcomplications |
| 650 | 0 | 4 |
_aHIV Protease Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aHIV Wasting Syndrome _xcomplications |
| 650 | 0 | 4 | _aHormone Replacement Therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMusculoskeletal Physiological Phenomena _xdrug effects |
| 650 | 0 | 4 |
_aOxandrolone _xtherapeutic use |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 |
_aTestosterone _xtherapeutic use |
| 700 | 1 | _aBarbieri, T | |
| 700 | 1 | _aVan Loan, M | |
| 700 | 1 | _aParks, E | |
| 700 | 1 | _aCatlin, D | |
| 700 | 1 | _aBarton, N | |
| 700 | 1 | _aNeese, R | |
| 700 | 1 | _aChristiansen, M | |
| 700 | 1 | _aKing, J | |
| 700 | 1 | _aHellerstein, M K | |
| 773 | 0 |
_tJAMA _gvol. 281 _gno. 14 _gp. 1282-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/jama.281.14.1282 _zAvailable from publisher's website |
| 999 |
_c10167457 _d10167457 |
||